These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32236239)

  • 21. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
    Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
    Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pH and reduction dual-sensitive polymeric nanomicelle for tumor microenvironment triggered cellular uptake and controlled intracellular drug release.
    Su Z; Xu Y; Wang Y; Shi W; Han S; Shuai X
    Biomater Sci; 2019 Aug; 7(9):3821-3831. PubMed ID: 31268075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
    Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversing the undesirable pH-profile of doxorubicin via activation of a di-substituted maleamic acid prodrug at tumor acidity.
    Zhang A; Yao L; An M
    Chem Commun (Camb); 2017 Nov; 53(95):12826-12829. PubMed ID: 29143021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leveraging a polycationic polymer to direct tunable loading of an anticancer agent and photosensitizer with opposite charges for chemo-photodynamic therapy.
    Zhao M; Wan S; Peng X; Zhang B; Pan Q; Li S; He B; Pu Y
    J Mater Chem B; 2020 Feb; 8(6):1235-1244. PubMed ID: 31957757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug.
    Chen K; Cai H; Zhang H; Zhu H; Gu Z; Gong Q; Luo K
    Acta Biomater; 2019 Jan; 84():339-355. PubMed ID: 30503561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjugated Polymer Nanoparticles Based on Copper Coordination for Real-Time Monitoring of pH-Responsive Drug Delivery.
    Li J; Du N; Tan Y; Hsu HY; Tan C; Jiang Y
    ACS Appl Bio Mater; 2021 Mar; 4(3):2583-2590. PubMed ID: 35014375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilayer Nanocarriers with Protein-Acid Conjugation for Prolonged Release and Enhanced Anticancer Effects.
    Hou H; Zhang D; Zeng J; Zhou L; Wang Z; Yao M; Ren J; Hu N; Wang Y
    Langmuir; 2019 Mar; 35(10):3710-3716. PubMed ID: 30727729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combretastatin A4 Nanodrug-Induced MMP9 Amplification Boosts Tumor-Selective Release of Doxorubicin Prodrug.
    Jiang J; Shen N; Ci T; Tang Z; Gu Z; Li G; Chen X
    Adv Mater; 2019 Nov; 31(44):e1904278. PubMed ID: 31549774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinspired polynorepinephrine nanoparticles as an efficient vehicle for enhanced drug delivery.
    Lu Z; Douek AM; Rozario AM; Tabor RF; Kaslin J; Follink B; Teo BM
    J Mater Chem B; 2020 Feb; 8(5):961-968. PubMed ID: 31922181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
    Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
    Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.
    Mao X; Si J; Huang Q; Sun X; Zhang Q; Shen Y; Tang J; Liu X; Sui M
    Adv Healthc Mater; 2016 Oct; 5(19):2517-2527. PubMed ID: 27529558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
    Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
    J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation.
    Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R
    ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutathione-Responsive Multifunctional "Trojan Horse" Nanogel as a Nanotheranostic for Combined Chemotherapy and Photodynamic Anticancer Therapy.
    Wang Y; Zu M; Ma X; Jia D; Lu Y; Zhang T; Xue P; Kang Y; Xu Z
    ACS Appl Mater Interfaces; 2020 Nov; 12(45):50896-50908. PubMed ID: 33107728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
    Yuan X; Peng S; Lin W; Wang J; Zhang L
    J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.
    Garsky VM; Lumma PK; Feng DM; Wai J; Ramjit HG; Sardana MK; Oliff A; Jones RE; DeFeo-Jones D; Freidinger RM
    J Med Chem; 2001 Nov; 44(24):4216-24. PubMed ID: 11708923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zwitterionic Polypeptide-Based Nanodrug Augments pH-Triggered Tumor Targeting
    Xue W; Trital A; Shen J; Wang L; Chen S
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):46639-46652. PubMed ID: 32893614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradable phosphorylcholine-based zwitterionic polymer nanogels with smart charge-conversion ability for efficient inhibition of tumor cells.
    Peng S; Men Y; Xie R; Tian Y; Yang W
    J Colloid Interface Sci; 2019 Mar; 539():19-29. PubMed ID: 30572286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.